HE Li-qun

975 total citations
56 papers, 666 citations indexed

About

HE Li-qun is a scholar working on Complementary and alternative medicine, Nephrology and Molecular Biology. According to data from OpenAlex, HE Li-qun has authored 56 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Complementary and alternative medicine, 18 papers in Nephrology and 9 papers in Molecular Biology. Recurrent topics in HE Li-qun's work include Renal Diseases and Glomerulopathies (12 papers), Traditional Chinese Medicine Studies (9 papers) and Natural Compounds in Disease Treatment (6 papers). HE Li-qun is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Traditional Chinese Medicine Studies (9 papers) and Natural Compounds in Disease Treatment (6 papers). HE Li-qun collaborates with scholars based in China, United States and South Korea. HE Li-qun's co-authors include Yanlin Wang, Hua Liang, Feixia Dong, Jing Xu, Mark L. Entman, Gang Chen, Shuhua Han, Jie Du, Xiaogao Jin and Zhengmao Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of the American Society of Nephrology.

In The Last Decade

HE Li-qun

54 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HE Li-qun China 15 279 215 104 95 88 56 666
Lirong Hao China 17 199 0.7× 287 1.3× 131 1.3× 37 0.4× 25 0.3× 34 763
Qi Bian China 13 223 0.8× 322 1.5× 122 1.2× 47 0.5× 17 0.2× 25 681
Tangli Xiao China 15 534 1.9× 378 1.8× 78 0.8× 31 0.3× 27 0.3× 29 1.1k
Lawrence Lu United States 7 234 0.8× 175 0.8× 162 1.6× 40 0.4× 29 0.3× 8 709
Aolei Niu United States 14 305 1.1× 295 1.4× 234 2.3× 24 0.3× 22 0.3× 17 825
Zeyuan Lu China 15 246 0.9× 249 1.2× 69 0.7× 15 0.2× 36 0.4× 29 715
Xinli Xu China 9 322 1.2× 246 1.1× 48 0.5× 24 0.3× 22 0.3× 12 690
Yaping Fan China 17 116 0.4× 254 1.2× 78 0.8× 28 0.3× 20 0.2× 40 626
Danyi Yang China 14 329 1.2× 260 1.2× 95 0.9× 31 0.3× 16 0.2× 28 720
Kazushi Tsuruga Japan 19 340 1.2× 210 1.0× 323 3.1× 45 0.5× 22 0.3× 55 920

Countries citing papers authored by HE Li-qun

Since Specialization
Citations

This map shows the geographic impact of HE Li-qun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HE Li-qun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HE Li-qun more than expected).

Fields of papers citing papers by HE Li-qun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HE Li-qun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HE Li-qun. The network helps show where HE Li-qun may publish in the future.

Co-authorship network of co-authors of HE Li-qun

This figure shows the co-authorship network connecting the top 25 collaborators of HE Li-qun. A scholar is included among the top collaborators of HE Li-qun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HE Li-qun. HE Li-qun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Jubao, et al.. (2025). Wenyang Xiaozheng decoction modulates macrophage polarization via JAK2/STAT3 signaling pathway to reduce renal fibrosis. Journal of Ethnopharmacology. 354. 120497–120497.
2.
Zhao, Bin, et al.. (2024). Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS. Frontiers in Pharmacology. 15. 1438292–1438292. 1 indexed citations
3.
Wang, Dong, HE Li-qun, & Xiaotian Zhang. (2021). -308G/A polymorphism of tumor necrosis factor alpha (TNF-α) gene and metabolic syndrome susceptibility: a meta-analysis. Scientific Reports. 11(1). 3840–3840. 7 indexed citations
4.
Wan, Qiang, et al.. (2018). Effect and Mechanism of ShiZhiFang on Uric Acid Metabolism in Hyperuricemic Rats. Evidence-based Complementary and Alternative Medicine. 2018(1). 6821387–6821387. 14 indexed citations
5.
He, Fei, Huiling Wang, Qiang Wan, et al.. (2017). Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 7674240–7674240. 15 indexed citations
6.
Sun, Chuan, et al.. (2016). A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy. BMC Complementary and Alternative Medicine. 16(1). 312–312. 7 indexed citations
7.
Li-qun, HE, et al.. (2015). Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cells. BMC Complementary and Alternative Medicine. 15(1). 378–378. 17 indexed citations
8.
Zhou, Hua, et al.. (2014). Effect of Shenxinning decoction on ventricular remodeling in AT1 receptor-knockout mice with chronic renal insufficiency. Indian Journal of Pharmacology. 46(4). 391–391. 2 indexed citations
9.
Li-qun, HE. (2012). Effects of Salvianolate on Renal Function and Renal Oxygen Consumption in Rats with Chronic Renal Failure. 1 indexed citations
10.
Li-qun, HE. (2011). Clinical Effects of "No.II Renal Failure Recipe" on Patients with Chronic Kidney Disease at 3-4 Stage. 1 indexed citations
11.
Li-qun, HE. (2011). Experimental study on role of TGF-β1/p38 mitogen-activated protein kinase pathway to renal interstitial fibrosis and intervention mechanisms of Kang Xianling Decoction. Zhonghua zhongyiyao zazhi. 2 indexed citations
12.
Li-qun, HE. (2011). Treatment of 33 cases of hyperuricemic nephropathy of phlegm-blood stasis by "Shizhi Decoction". Shanghai Journal of Traditional Chinese Medicine. 4 indexed citations
13.
Xiong, Ji, Hu Wang, Guangming Guo, et al.. (2011). Male Germ Cell Apoptosis and Epigenetic Histone Modification Induced by Tripterygium wilfordii Hook F. PLoS ONE. 6(6). e20751–e20751. 30 indexed citations
14.
Li-qun, HE. (2010). Effects of "Tailin Decoction" on renal scarring suppression in chronic pyelonephrits rats. Shanghai Journal of Traditional Chinese Medicine. 2 indexed citations
15.
Li-qun, HE. (2010). Correlativity between Chinese medical syndromes and clinical prognosis of IgA nephropathy. Shanghai Journal of Traditional Chinese Medicine. 2 indexed citations
16.
Li-qun, HE. (2009). Effects of Glycosides of Tripterygium Wilfordii on Reproduction Capacity and Its Intervention by Caulis Cistanchi in Male Mice. Shanghai Journal of Traditional Chinese Medicine. 2 indexed citations
17.
Huang, Di, Jie Li, & HE Li-qun. (2009). Influence of <I>Tripterygium wilfordii</I> on the expression of sper-miogenesis related genes <I>Herc4, Ipo11</I> and <I>Mrto4</I> in mice. Hereditas (Beijing). 31(9). 941–946. 11 indexed citations
18.
Li-qun, HE, et al.. (2007). Useful indicators for performing renal biopsy in adult patients with isolated microscopic haematuria. International Journal of Clinical Practice. 61(5). 789–794. 13 indexed citations
19.
Li-qun, HE. (2006). Cardiovascular Complications and Its Chinese Medical Syndromes of Chronic Renal Failure. Shanghai Journal of Traditional Chinese Medicine. 1 indexed citations
20.
Li-qun, HE. (2003). Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy. Journal of Chinese Integrative Medicine. 1(2). 119–121. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lirong Hao Breakdown of academic impact, for papers by Qi Bian Breakdown of academic impact, for papers by Tangli Xiao Breakdown of academic impact, for papers by Lawrence Lu Breakdown of academic impact, for papers by Aolei Niu Breakdown of academic impact, for papers by Zeyuan Lu Breakdown of academic impact, for papers by Xinli Xu Breakdown of academic impact, for papers by Yaping Fan Breakdown of academic impact, for papers by Danyi Yang Breakdown of academic impact, for papers by Kazushi Tsuruga
Rankless by CCL
2026